Search by Drug Name or NDC

    NDC 60505-4665-09 Tasimelteon 20 mg/1 Details

    Tasimelteon 20 mg/1

    Tasimelteon is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is TASIMELTEON.

    Product Information

    NDC 60505-4665
    Product ID 60505-4665_2d32bb85-3df0-b9c6-0fd1-bf559cdc6550
    Associated GPIs
    GCN Sequence Number 072007
    GCN Sequence Number Description tasimelteon CAPSULE 20 MG ORAL
    HIC3 H8B
    HIC3 Description HYPNOTICS, MELATONIN MT1/MT2 RECEPTOR AGONISTS
    GCN 36068
    HICL Sequence Number 040927
    HICL Sequence Number Description TASIMELTEON
    Brand/Generic Generic
    Proprietary Name Tasimelteon
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tasimelteon
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name TASIMELTEON
    Labeler Name Apotex Corp.
    Pharmaceutical Class Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211607
    Listing Certified Through 2025-12-31

    Package

    NDC 60505-4665-09 (60505466509)

    NDC Package Code 60505-4665-9
    Billing NDC 60505466509
    Package 90 CAPSULE in 1 BOTTLE (60505-4665-9)
    Marketing Start Date 2024-01-05
    NDC Exclude Flag N
    Pricing Information N/A